Is Cancer Research Agent 2025 Safe?
Cancer Research Agent 2025 — Nerq Trust Score 70.0/100 (B grade). Based on analysis of 5 trust dimensions, it is generally safe but has some concerns. Last updated: 2026-05-04.
Yes, Cancer Research Agent 2025 is safe to use. Cancer Research Agent 2025 is a software tool with a Nerq Trust Score of 70.0/100 (B), based on 5 independent data dimensions. Recommended for use. Security: 0/100. Maintenance: 1/100. Popularity: 0/100. Data sourced from multiple public sources including package registries, GitHub, NVD, OSV.dev, and OpenSSF Scorecard. Last updated: 2026-05-04. Machine-readable data (JSON).
Is Cancer Research Agent 2025 safe?
YES — Cancer Research Agent 2025 has a Nerq Trust Score of 70.0/100 (B). It meets Nerq's trust threshold with strong signals across security, maintenance, and community adoption. Recommended for use — review the full report below for specific considerations.
What is Cancer Research Agent 2025's trust score?
Cancer Research Agent 2025 has a Nerq Trust Score of 70.0/100, earning a B grade. This score is based on 5 independently measured dimensions including security, maintenance, and community adoption.
What are the key security findings for Cancer Research Agent 2025?
Cancer Research Agent 2025's strongest signal is compliance at 48/100. No known vulnerabilities have been detected. It meets the Nerq Verified threshold of 70+.
What is Cancer Research Agent 2025 and who maintains it?
| Author | Sugi-Hcr |
| Category | Health |
| Stars | 2 |
| Source | https://github.com/Sugi-Hcr/cancer-research-agent-2025 |
| Protocols | rest |
Regulatory Compliance
| EU AI Act Risk Class | MINIMAL |
| Compliance Score | 48/100 |
| Jurisdictions | Assessed across 52 jurisdictions |
Popular Alternatives in health
What Is Cancer Research Agent 2025?
Cancer Research Agent 2025 is a software tool in the health category: A multi-agent AI system for enhancing cancer treatment decisions under physician oversight.. It has 2 GitHub stars. Nerq Trust Score: 70/100 (B).
Nerq independently analyzes every software tool, app, and extension across multiple trust signals including security vulnerabilities, maintenance activity, license compliance, and community adoption.
How Nerq Assesses Cancer Research Agent 2025's Safety
Nerq's Trust Score is calculated from 13+ independent signals aggregated into five dimensions. Here is how Cancer Research Agent 2025 performs in each:
- Security (0/100): Cancer Research Agent 2025's security posture is poor. This score factors in known CVEs, dependency vulnerabilities, security policy presence, and code signing practices.
- Maintenance (1/100): Cancer Research Agent 2025 is potentially abandoned. We track commit frequency, release cadence, issue response times, and PR merge rates.
- Documentation (1/100): Documentation quality is insufficient. This includes README completeness, API documentation, usage examples, and contribution guidelines.
- Compliance (48/100): Cancer Research Agent 2025 is compliance gaps exist. Assessed against regulations in 52 jurisdictions including the EU AI Act, CCPA, and GDPR.
- Community (0/100): Community adoption is limited. Based on GitHub stars, forks, download counts, and ecosystem integrations.
The overall Trust Score of 70.0/100 (B) reflects the weighted combination of these signals. This exceeds the Nerq Verified threshold of 70, indicating the tool meets our standards for production use.
Who Should Use Cancer Research Agent 2025?
Cancer Research Agent 2025 is designed for:
- Developers and teams working with health tools
- Organizations evaluating AI tools for their stack
- Researchers exploring AI capabilities in this domain
Risk guidance: Cancer Research Agent 2025 meets the minimum threshold for production use, but we recommend monitoring for security advisories and keeping dependencies up to date. Consider implementing additional guardrails for sensitive workloads.
How to Verify Cancer Research Agent 2025's Safety Yourself
While Nerq provides automated trust analysis, we recommend these additional steps before adopting any software tool:
- Check the source code — Review the repository's security policy, open issues, and recent commits for signs of active maintenance.
- Scan dependencies — Use tools like
npm audit,pip-audit, orsnykto check for known vulnerabilities in Cancer Research Agent 2025's dependency tree. - Review permissions — Understand what access Cancer Research Agent 2025 requires. Software tools should follow the principle of least privilege.
- Test in isolation — Run Cancer Research Agent 2025 in a sandboxed environment before granting access to production data or systems.
- Monitor continuously — Use Nerq's API to set up automated trust checks:
GET nerq.ai/v1/preflight?target=cancer-research-agent-2025 - Review the license — Confirm that Cancer Research Agent 2025's license is compatible with your intended use case. Pay attention to restrictions on commercial use, redistribution, and derivative works. Some AI tools use dual licensing or have separate terms for enterprise customers that differ from the open-source license.
- Check community signals — Look at the project's issue tracker, discussion forums, and social media presence. A healthy community actively reports bugs, contributes fixes, and discusses security concerns openly. Low community engagement may indicate limited peer review of the codebase.
Common Safety Concerns with Cancer Research Agent 2025
When evaluating whether Cancer Research Agent 2025 is safe, consider these category-specific risks:
Understand how Cancer Research Agent 2025 processes, stores, and transmits your data. Review the tool's privacy policy and data retention practices, especially for sensitive or proprietary information.
Check Cancer Research Agent 2025's dependency tree for known vulnerabilities. Tools with outdated or unmaintained dependencies pose a higher security risk.
Regularly check for updates to Cancer Research Agent 2025. Security patches and bug fixes are only effective if you're running the latest version.
If Cancer Research Agent 2025 connects to external APIs or services, each integration point is a potential attack surface. Audit all third-party connections, verify that data shared with external services is minimized, and ensure that integration credentials are rotated regularly.
Verify that Cancer Research Agent 2025's license is compatible with your intended use case. Some AI tools have restrictive licenses that limit commercial use, redistribution, or derivative works. Using Cancer Research Agent 2025 in violation of its license can expose your organization to legal liability.
Cancer Research Agent 2025 and the EU AI Act
Cancer Research Agent 2025 is classified as Minimal Risk under the EU AI Act. This is the lowest risk category, meaning it faces minimal regulatory requirements. However, transparency obligations still apply.
Nerq's compliance assessment covers 52 jurisdictions worldwide. For organizations deploying AI tools in regulated environments, understanding these classifications is essential for legal compliance.
Best Practices for Using Cancer Research Agent 2025 Safely
Whether you're an individual developer or an enterprise team, these practices will help you get the most from Cancer Research Agent 2025 while minimizing risk:
Periodically review how Cancer Research Agent 2025 is used in your workflow. Check for unexpected behavior, permissions drift, and compliance with your security policies.
Ensure Cancer Research Agent 2025 and all its dependencies are running the latest stable versions to benefit from security patches.
Grant Cancer Research Agent 2025 only the minimum permissions it needs to function. Avoid granting admin or root access.
Subscribe to Cancer Research Agent 2025's security advisories and vulnerability disclosures. Use Nerq's API to get automated trust score updates.
Create and maintain a clear policy for how Cancer Research Agent 2025 is used within your organization, including data handling guidelines and acceptable use cases.
When Should You Avoid Cancer Research Agent 2025?
Even well-trusted tools aren't right for every situation. Consider avoiding Cancer Research Agent 2025 in these scenarios:
- Scenarios where Cancer Research Agent 2025's specific capabilities exceed your actual needs — simpler tools may be safer
- Air-gapped environments where the tool cannot receive security updates
- Projects with strict regulatory requirements that haven't been explicitly validated
For each scenario, evaluate whether Cancer Research Agent 2025's trust score of 70.0/100 meets your organization's risk tolerance. The Nerq Verified status indicates general production readiness, but sector-specific requirements may apply.
How Cancer Research Agent 2025 Compares to Industry Standards
Nerq indexes over 6 million software tools, apps, and packages across dozens of categories. Among health tools, the average Trust Score is 62/100. Cancer Research Agent 2025's score of 70.0/100 is above the category average of 62/100.
This positions Cancer Research Agent 2025 favorably among health tools. While it outperforms the average, there is still room for improvement in certain trust dimensions.
Industry benchmarks matter because they contextualize a tool's safety profile. A score that looks moderate in isolation may actually represent strong performance within a challenging category — or vice versa. Nerq's category-relative analysis helps teams make informed decisions by showing not just absolute quality, but how a tool ranks against its direct peers.
Trust Score History
Nerq continuously monitors Cancer Research Agent 2025 and recalculates its Trust Score as new data becomes available. Our scoring engine ingests real-time signals from source repositories, vulnerability databases (NVD, OSV.dev), package registries, and community metrics. When a new CVE is published, a major release ships, or maintenance patterns change, Cancer Research Agent 2025's score is updated within 24 hours.
Historical trust trends reveal whether a tool is improving, stable, or declining over time. A tool that consistently maintains or improves its score demonstrates ongoing commitment to security and quality. Conversely, a downward trend may signal reduced maintenance, growing technical debt, or unresolved vulnerabilities. To track Cancer Research Agent 2025's score over time, use the Nerq API: GET nerq.ai/v1/preflight?target=cancer-research-agent-2025&include=history
Nerq retains trust score snapshots at regular intervals, enabling trend analysis across weeks and months. Enterprise users can access detailed historical reports showing how each dimension — security, maintenance, documentation, compliance, and community — has evolved independently, providing granular visibility into which aspects of Cancer Research Agent 2025 are strengthening or weakening over time.
Cancer Research Agent 2025 vs Alternatives
In the health category, Cancer Research Agent 2025 scores 70.0/100. There are higher-scoring alternatives available. For a detailed comparison, see:
- Cancer Research Agent 2025 vs MedicalGPT — Trust Score: 64.3/100
- Cancer Research Agent 2025 vs open-health — Trust Score: 57.9/100
- Cancer Research Agent 2025 vs Awesome-AI4Med — Trust Score: 58.9/100
Key Takeaways
- Cancer Research Agent 2025 has a Trust Score of 70.0/100 (B) and is Nerq Verified.
- Cancer Research Agent 2025 meets the minimum threshold for production deployment, though monitoring and additional guardrails are recommended.
- Among health tools, Cancer Research Agent 2025 scores above the category average of 62/100, demonstrating above-average reliability.
- Always verify safety independently — use Nerq's Preflight API for automated, up-to-date trust checks before integration.
Detailed Score Analysis
| Dimension | Score |
|---|---|
| Security | 0/100 |
| Maintenance | 1/100 |
| Popularity | 0/100 |
Based on 3 dimensions. Data from multiple public sources including package registries, GitHub, NVD, OSV.dev, and OpenSSF Scorecard.
What data does Cancer Research Agent 2025 collect?
Privacy assessment for Cancer Research Agent 2025 is not yet available. See our methodology for how Nerq measures privacy, or the public privacy review for any community-contributed notes.
Is Cancer Research Agent 2025 secure?
Security score: 0/100. Review security practices and consider alternatives with higher security scores for sensitive use cases.
Nerq monitors this entity against NVD, OSV.dev, and registry-specific vulnerability databases for ongoing security assessment.
Full analysis: Cancer Research Agent 2025 Security Report
How we calculated this score
Cancer Research Agent 2025's trust score of 70.0/100 (B) is computed from multiple public sources including package registries, GitHub, NVD, OSV.dev, and OpenSSF Scorecard. The score reflects 3 independent dimensions: security (0/100), maintenance (1/100), popularity (0/100). Each dimension is weighted equally to produce the composite trust score.
Nerq analyzes over 7.5 million entities across 26 registries using the same methodology, enabling direct cross-entity comparison. Scores are updated continuously as new data becomes available.
This page was last reviewed on May 04, 2026. Data version: 1.0.
Full methodology documentation · Machine-readable data (JSON API)
Frequently Asked Questions
Is Cancer Research Agent 2025 Safe?
What is Cancer Research Agent 2025's trust score?
What are safer alternatives to Cancer Research Agent 2025?
How often is Cancer Research Agent 2025's safety score updated?
Can I use Cancer Research Agent 2025 in a regulated environment?
See Also
Disclaimer: Nerq trust scores are automated assessments based on publicly available signals. They are not endorsements or guarantees. Always conduct your own due diligence.